Posted in | News | Gold

Harte Gold Corp. to Focus on Diamond Drill Program at New Drilling Zone

HARTE GOLD CORP. ("Harte") (TSX VENTURE:HRT)(FRANKFURT:H4O) is pleased to announce assay results of up to 28.3 g/t from recent trenching and sampling at the new disseminated sulphide, meta-sediment, gold discovery on the Sugar Zone Property.

Assays

Current assays returned values of 28.3 g/t, 9.49 g/t, 6.35 g/t, 5.1 g/t and 2.5 g/t from grab samples taken from bedrock located north of the area of previous sampling (6.53 g/t and 5.97 g/t grab samples see press release September 21, 2010). Current assays represent a northward extension of the Trench 2 Zone. Five other grab samples taken in the area returned anomalous gold values of 410, 237, 60, 59 and 30 ppb. The Company is continuing to excavate and sample areas associated with recently discovered IP anomalies.

Overburden was cleared with an excavator to expose fresh bedrock which was sampled by Mr. George A. Flach, P.Geo., VP Exploration of Harte. This mineralization may not be representative of future drill results. All samples were assayed at Activation Laboratories, Thunder Bay, Ontario using standard fire assay methods with AA finish.

Drill Program

The Company also announced it is accelerating the start of a diamond drill program to focus on the new discovery zone. A drill rig will arrive on site next week to begin a 1,500 metre program to test certain IP anomalies, particularly where surface sampling has shown gold mineralization.

Once road improvements are completed at least one additional drill rig will arrive on site to resume drilling on the Sugar Zone.

Source:

Harte Gold Corp.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.